Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Lung Adenocarcinoma (MSKCC, Science 2015)	BL3403	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Y956N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP			NA	NA	NA	19	50919698	50919698	T	A	19:g.50919698T>A	ENST00000440232.2:c.2866T>A	0.25		2	6		9	143	23/27					2	73	Pembrolizumab (Dose 10 mg/kg)	No durable benefit	Progression-free Survival	0.7476	Adenocarcinoma	Transversion Low	99	148	Self reported self status	LUAD	Weak(1-49% membraneous staining	6.5	1	1	Female	Former	43.75	Matched	4.73333333333	261	SD																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	HE3202	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A935T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP			NA	NA	NA	19	50919066	50919066	G	A	19:g.50919066G>A	ENST00000440232.2:c.2803G>A	0.22		2	7		9	724	22/27		Uncertain_significance		0.00014	3	63	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	0.9029	Adenocarcinoma	Transversion High	610	746	Self reported self status	LUAD	Strong(>or =50% membraneous staining)	14.7	3	1	Female	Former	58	Matched	24.1333333333	1011	PR																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	M4945	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	I927V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP			NA	NA	NA	19	50919042	50919042	A	G	19:g.50919042A>G	ENST00000440232.2:c.2779A>G	0.18		2	9		11	416	22/27					2	66	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	0.6676	Adenocarcinoma	Transversion High	300	427	Self reported self status	LUAD	Unassessable	14.6	3	1	Male	Former	40	Matched	13.9	685	PR																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	SA9755	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	C284Y	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.987	Missense_Mutation	SNP			NA	NA	NA	19	50905879	50905879	G	A	19:g.50905879G>A	ENST00000440232.2:c.851G>A	0.25		2	6		19	1166	8/27					3	63	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Censored	1.0000	NSCLC NOS	Transversion High	576	1192	Self reported self status	LUAD	Weak(1-49% membraneous staining	8.4	1	1	Female	Former	36	Matched	38.8	1732	PR																																																	
Lung Adenocarcinoma (MSKCC, Science 2015)	Y2087	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	E374K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.968	Missense_Mutation	SNP			NA	NA	NA	19	50906459	50906459	G	A	19:g.50906459G>A	ENST00000440232.2:c.1120G>A	0.22		2	7		8	491	9/27					3	68	Pembrolizumab (Dose 10 mg/kg)	Durable clinical benefit beyond 6 months	Progression-free Survival	0.9315	Adenocarcinoma	Transversion Low	358	507	Self reported self status	LUAD	Weak(1-49% membraneous staining	8.3	5	1	Female	Never	0	Matched	16.3666666667	914	SD																																																	
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0004472-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	T582R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.339	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	19	50910642	50910642	C	G	19:g.50910642C>G	ENST00000440232.2:c.1745C>G	0.12	0.0011	28	206	1	893	15	14/27						62		NO		0.3057						LUAD		4.0		1	Female			Matched	13.7020757666					IMPACT410																							1:Progressed																	0.31	Commercial	2	14.1509434		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0007084-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G178V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.17;Polyphen-2: impact: benign, score: 0.117	Missense_Mutation	SNP	Diploid	1	SOMATIC	Unknown	MSKCC	19	50905325	50905325	G	T	19:g.50905325G>T	ENST00000440232.2:c.533G>T	0.20	0.0027	39	154	1	372	9	5/27						83		NO		0.2106						LUAD		1.63		1	Male			Matched	8.80847727853					IMPACT410																							1:Progressed																	0.21	Clinical trial	1	8.490566038	25	Ever	Combination
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0009202-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	G12R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.05;Polyphen-2: impact: benign, score: 0.094	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	19	50902142	50902142	G	A	19:g.50902142G>A	ENST00000440232.2:c.34G>A	0.19		105	455		475	12	2/27	0.00004128509232847921	Uncertain_significance	rs772197667			66		NE		0.2907						LUSC		3.47		1	Male			Matched	11.7446363714					IMPACT410																							0:Not Progressed																	0.29	Commercial	2	11.32075472	60	Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0012931-T01-IM5	Non-Small Cell Lung Cancer	Lung Squamous Cell Carcinoma	G64R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.15;Polyphen-2: impact: benign, score: 0.202	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	19	50902298	50902298	G	A	19:g.50902298G>A	ENST00000440232.2:c.190G>A	0.30	0.0005	708	1663	1	1892	10	2/27						71		NO		0.2469						LUSC		2.0		1	Male			Matched	9.78719697615					IMPACT410																							1:Progressed																	0.25	Commercial	2	9.433962264		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s60	Lung cancer	Lung Adenocarcinoma	R180Gfs*3	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL			NA	NA	MSKCC	19	50905324	50905324	G	-	19:g.50905324del	ENST00000440232.2:c.537del	0.07		10	132			1469	5/27								Durable Clinical Benefit			Non-Squamous			1358		LUAD		24.3121		1	Female			Matched	49.1																												0:Censor					73	PR	0	A*30:01	A*02:01	B*44:02	B*13:02	C*05:01	C*06:02	15.0	4350	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s74	Lung cancer	Lung Adenocarcinoma	R352C	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.02;Polyphen-2: impact: benign, score: 0.189	Missense_Mutation	SNP		1	NA	NA	MSKCC	19	50906393	50906393	C	T	19:g.50906393C>T	ENST00000440232.2:c.1054C>T	0.22		48	173			696	9/27	0.0000237985	Uncertain_significance	rs762330164	0.00014				Durable Clinical Benefit			Non-Squamous			625		LUAD		7.9836		1	Male			Matched	23.2666666667																												1:Event					42	SD	1	A*03:01	A*26:01	B*44:02	B*38:01	C*07:04	C*12:03	15.0	1295	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s10	Lung cancer	Lung Adenocarcinoma	D445Y	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: possibly_damaging, score: 0.722	Missense_Mutation	SNP			NA	NA	MSKCC	19	50909529	50909529	G	T	19:g.50909529G>T	ENST00000440232.2:c.1333G>T	0.35		25	47			269	11/27								No Durable Benefit			Squamous			239		LUAD		5.4209		1	Male			Matched	8.96666666667																												1:Event					72	SD	1	A*01:01	A*03:01	B*07:02	B*15:01	C*07:02	C*03:04	25.0	780	Former							
Non-Small Cell Lung Cancer (MSK, Cancer Cell 2018)	nsclc_mskcc_2018s60	Lung cancer	Lung Adenocarcinoma	Q1038E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP			NA	NA	MSKCC	19	50920346	50920346	C	G	19:g.50920346C>G	ENST00000440232.2:c.3112C>G	0.11		10	77			1469	25/27								Durable Clinical Benefit			Non-Squamous			1358		LUAD		24.3121		1	Female			Matched	49.1																												0:Censor					73	PR	0	A*30:01	A*02:01	B*44:02	B*13:02	C*05:01	C*06:02	15.0	4350	Former							
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005178-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A930T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	50919051	50919051	G	A	19:g.50919051G>A	ENST00000440232.2:c.2788G>A							5	22/27	0.0000680079	Uncertain_significance	rs144111108			50		YES		0.4200						LUAD				1	Female	Never		Matched	4.89359848807			YES	EGFR	IMPACT410	YES	MSKCC	3		Adenocarcinoma	Lung	YES	Tumor	561	NO	Primary	Note: The CDK12, ERBB2, and RARA copy number gain falls slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	YES	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009508-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X985_splice	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	19	50919786	50919786	G	A	19:g.50919786G>A	ENST00000440232.2:c.2953+1G>A							10			Uncertain_significance	rs1555793361			79				0.2446						LUAD				1	Male	Former heavy		Matched	8.80847727853			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	0	Liver	Adenocarcinoma	Lung	YES	Tumor	861	YES	Metastasis		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004114-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R225H	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.03;Polyphen-2: impact: benign, score: 0.289	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	50905546	50905546	G	A	19:g.50905546G>A	ENST00000440232.2:c.674G>A							45	6/27	0.0000203679	Uncertain_significance	rs144979965			47				0.1172						LUAD				1	Male	Former heavy		Matched	44.0423863927			NO	UNKNOWN DRIVER	IMPACT410	YES	MSKCC	2		Adenocarcinoma	Lung	YES	Tumor	685	NO	Primary	Note: The BCL2L1 and CRKL copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	NO	YES		DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009110-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V455L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.61;Polyphen-2: impact: benign, score: 0.106	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	19	50909559	50909559	G	T	19:g.50909559G>T	ENST00000440232.2:c.1363G>T							17	11/27						53				0.0000						LUAD				1	Female	Former heavy		Matched	16.6382348595			NO	BRCA	IMPACT410	NO	MSKCC	0		Adenocarcinoma	Lung	YES	Tumor	1102	YES	Primary	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	IV	NO	YES	10	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006713-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	A749S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.09;Polyphen-2: impact: possibly_damaging, score: 0.531	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	50916773	50916773	G	T	19:g.50916773G>T	ENST00000440232.2:c.2245G>T							46	18/27						48				0.5048						LUAD				2	Female	Former heavy		Matched	45.0211060903			NO	NF1_truncating	IMPACT410	YES	MSKCC	1	Liver	Adenocarcinoma	Lung	YES	Tumor	946	NO	Metastasis		IV	NO	YES	50	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004472-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	T582R	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.339	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	19	50910642	50910642	C	G	19:g.50910642C>G	ENST00000440232.2:c.1745C>G							15	14/27						61				0.3057						LUAD				1	Female	Former heavy		Matched	13.7020757666			NO	ERBB2	IMPACT410	YES	MSKCC	1	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	201	NO	Metastasis		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004114-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	X324_splice	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Splice_Site	SNP	Diploid		SOMATIC	NA	MSKCC	19	50905999	50905999	G	T	19:g.50905999G>T	ENST00000440232.2:c.970+1G>T							45			Uncertain_significance	rs1337231648			47				0.1172						LUAD				1	Male	Former heavy		Matched	44.0423863927			NO	UNKNOWN DRIVER	IMPACT410	YES	MSKCC	2		Adenocarcinoma	Lung	YES	Tumor	685	NO	Primary	Note: The BCL2L1 and CRKL copy number gains fall slightly below the cut off criteria for amplification. Confirmatory testing by an alternate method is suggested, if clinically indicated.	IV	NO	YES		DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0003923-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L357Rfs*36	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Frame_Shift_Del	DEL	Diploid	1	SOMATIC	NA	MSKCC	19	50906409	50906418	TGCGGCCCTG	GGGGGCCTT	19:g.50906409_50906418delinsGGGGGCCTT	ENST00000440232.2:c.1070_1079delinsGGGGGCCTT							11	9/27						67		YES		0.2123						LUAD				1	Female	Former heavy		Matched	10.7659166738			YES	EGFR	IMPACT410	NO	MSKCC	0	Lung	Adenocarcinoma	Lung	YES	Tumor	635	YES	Metastasis	Note: The EGFR exon20 p.S768I and p.C775Y  mutations occur in different alleles.    Note: The EGFR exon20 p.S768I and p.T790M mutations occur in cis (same alleles).	IV	YES	YES	40	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0004410-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	I659M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.927	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	50912463	50912463	C	G	19:g.50912463C>G	ENST00000440232.2:c.1977C>G							15	16/27						57				0.8111						LUAD				1	Male	Former heavy		Matched	14.6807954642			NO	UNKNOWN DRIVER	IMPACT410	NO	MSKCC	1	Brain	Adenocarcinoma	Lung	YES	Tumor	332	NO	Metastasis		IV	NO	YES	40	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0007084-T02-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	G178V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.17;Polyphen-2: impact: benign, score: 0.117	Missense_Mutation	SNP	Diploid	1	SOMATIC	NA	MSKCC	19	50905325	50905325	G	T	19:g.50905325G>T	ENST00000440232.2:c.533G>T							9	5/27						82				0.2106						LUAD				1	Male	Former light		Matched	8.80847727853			NO	KRAS	IMPACT410	NO	MSKCC	3	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	263	NO	Metastasis	Note: Copy number profile is suggestive of broad copy number gain on Chromosome 5p.	IIIB	NO	YES		AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009301-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	D102N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.971	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	50902729	50902729	G	A	19:g.50902729G>A	ENST00000440232.2:c.304G>A							1	3/27	0.0000119336	Uncertain_significance	rs766784938			69		YES		0.1256						LUAD				1	Male	Never		Matched	0.978719697615			NO	ALK	IMPACT410	NO	MSKCC	0	Soft Tissue	Adenocarcinoma	Lung	YES	Tumor	841	YES	Metastasis		IV	YES	NO	50	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0009715-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	R667L	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	19	50912486	50912486	G	T	19:g.50912486G>T	ENST00000440232.2:c.2000G>T							28	16/27						62				0.6224						LUAD				1	Male	Former heavy		Matched	27.4041515332			NO	KRAS	IMPACT410	NO	MSKCC	1	Brain	Adenocarcinoma	Lung	YES	Tumor	1008	NO	Metastasis		IIIB	NO	YES	65	AWD																													
Non-small cell lung cancer (MSK, Science 2015)	BL3403	Lung cancer	Lung Adenocarcinoma	Y956N	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP			Somatic	NA	MSKCC	19	50919698	50919698	T	A	19:g.50919698T>A	ENST00000440232.2:c.2866T>A							143	23/27								NDB			Adenocarcinoma	Transversion Low	99	148		LUAD	Weak	6.5	1	1	Female	Former		Matched	4.7	261												Tumor			Met							73	10	142.309651	178.814652	Stable Response	1:Event	FFPE	43.75	Pleura	2																			
Non-small cell lung cancer (MSK, Science 2015)	HE3202	Lung cancer	Lung Adenocarcinoma	A935T	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	Missense_Mutation	SNP			Somatic	NA	MSKCC	19	50919066	50919066	G	A	19:g.50919066G>A	ENST00000440232.2:c.2803G>A							725	22/27		Uncertain_significance		0.00014				DCB			Adenocarcinoma	Transversion High	610	746		LUAD	Strong	14.7	3	1	Female	Former		Matched	24.0333333333	1011												Tumor			Met							63	10	89.139081	189.705252	Partial Response	0:Censure	FFPE	58.0	Lymph node	3																			
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0005034-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	POLD1-MYH14 fusion	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: NA;Polyphen-2: NA	fusion	FUSION	Diploid				MSKCC-DMP	NA	-1												6							60		YES		0.6423						LUAD				1	Male	Former light		Matched	5.87231818569			YES	EGFR	IMPACT410	NO	MSKCC	2	Lung	Adenocarcinoma	Lung	YES	Tumor	979	NO	Metastasis	Note: The EGFR p.L858R mutation frequency suggests that it is on the amplified allele.      Note: Copy number profile is suggestive of broad copy number loss on Chromosome arm 13q including BRCA2 and RB1 and Chromosome arm 3p including BAP1.   .	IV	YES	YES	70	DOD																													
